期刊文献+

血清癌胚抗原、基质金属蛋白酶3、血管内皮生长因子与胃癌微转移及预后关系的研究进展 被引量:9

Research Advances in Relationship between Serum CEA,MMP-3,VEGF and Micrometastasis,Prognosis of Gastric Cancer
下载PDF
导出
摘要 胃癌是最常见的消化道肿瘤之一,其病死率居所有恶性肿瘤的第2位。浸润和转移是恶性肿瘤的两大主要特点,同时也是一个复杂的多步骤、多环节的级联反应过程,其基础是肿瘤的微转移,检测到游离癌细胞为发现转移的金标准,在外周血中检测到特异的标志物或mRNA,可直接推测肿瘤细胞存在于外周血中。该文就血清癌胚抗原、基质金属蛋白酶3、血管内皮生长因子与胃癌微转移及预后的应用前景予以综述。 Gastric Cancer is one of the most common gastrointestinal tumors, the mortality of which ranks secnnd in all the malignant tumor, lnfihratinn and metastasis are two main features of malignant tumors, which is also a eomplex multi-step and multi-link cascaded process. The basis of infiltration and metastasis is the mierometastasis of the tumnr, anti the detection of the tree cancer cells is the g^lden criterion for the dis- covery of metastasis. If the spec, ific marker or mRNA are detected in the peripheral blond, it (:an be directly conjectured that the tumor cells exist in the peripheral blnml. Here is to make a review nn the prospect of the application nf serum CEA, MMP-3 ,VEGF and micrometastasis in gastric: cancer and its prognosis.
作者 许威 刘宏斌
出处 《医学综述》 2013年第11期1982-1985,共4页 Medical Recapitulate
关键词 癌胚抗原 基质金属蛋白酶3 血管内皮生长因子 胃癌 微转移 Carcino-embryonic antigen Matrix metalloproteinase-3 Vascular endothelial growth tacttor Gastric cancer Micrometastasis /
  • 相关文献

参考文献10

二级参考文献88

共引文献114

同被引文献91

  • 1季加孚.胃肠道恶性肿瘤外科的无瘤技术和原则[J].中国实用外科杂志,2005,25(4):254-256. 被引量:66
  • 2夏加增,孙晓光,赵伟,周宏,姚路斌.病检阴性胃癌淋巴结转移的检测:免疫组化和RT-PCR的比较[J].南通大学学报(医学版),2005,25(3):164-165. 被引量:3
  • 3赵明,季晓鹏,李会军,宋华.胃癌病变分期与相关肿瘤标志物血清含量的关系探讨[J].放射免疫学杂志,2006,19(6):497-498. 被引量:6
  • 4WHO. Cancer control:knowledge into action:WHO guide for effective programmes[J].Early detection,2007.8.
  • 5Ayadi S,Daghfous A,Makni A. Prognostic factors in gastric carcinoma after RO resec-tIo n with D Ⅱ Iymph node dissection.Tunisian experience[J].{H}Tunisie Medicale,2012,(11):812-815.
  • 6Kaartinen MT,Murshed M,Karsenty G. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice[J].{H}Journal of Histochemistry and Cytochemistry,2007,(77):1591-1595.
  • 7Reiniger IW,Wolf A,Welge-Lussen U. Osteopontin as a serologic marker for metastatic uveal melanoma:results of apilot study[J].{H}American Journal of Ophthalmology,2007,(04):705-707.
  • 8Takahashi Y,Takeuchi T,Sakamoto S. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients:a prospective clinical study[J].{H}GASTRIC CANCER,2003,(03):142-145.
  • 9Van Cutsem E, de Haas S, Kang YK, et al. Bevacizumab in com- bination with chemotherapy as first-line therapy in advanced gas- tric cancer:a biomarker evaluation from the AVAGAST random- ized phase III trial[J]. J Clin Oncol, 2012, 30:2119-2127.
  • 10Clarke JM ,Humvitz HI. Targeted inhibition of VEGF receptor 2 : an update on ramucimmab[ J]. Expect Opin Biol Ther, 2013, 13:1187-1196.

引证文献9

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部